Bluefin Capital Management, LLC Ocugen, Inc. Transaction History
Bluefin Capital Management, LLC
- $337 Million
- Q2 2025
A detailed history of Bluefin Capital Management, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Bluefin Capital Management, LLC holds 30,500 shares of OCGN stock, worth $36,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,500Holding current value
$36,600% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding OCGN
# of Institutions
112Shares Held
64.6MCall Options Held
604KPut Options Held
253K-
Black Rock Inc. New York, NY17.9MShares$21.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.8MShares$17.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.06MShares$6.07 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$4.98 Million0.17% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$4.19 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $260M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...